This scientific statement presents considerations for clinical management regarding the
assessment and risk reduction of select pediatric populations at high risk for premature …

The prevalence of diabetes mellitus will likely increase globally from 371 million individuals
in 2013 to 552 million individuals in 2030. This epidemic is mainly attributable to type 2 …

Patients with type 1 diabetes (T1D) also present with lipid disorders. Quantitative
abnormalities of lipoproteins are observed in T1D patients with poor glycaemic control …

Atherosclerosis causes significant morbidity and mortality. Carotid intima-media thickness
(CIMT) predicts future cardiovascular and ischaemic stroke incidence. CIMT, a measure of …

Oxidized low-density lipoprotein (oxLDL) is known to activate inflammatory responses in a
variety of cells, especially macrophages and dendritic cells. Interestingly, much of the oxLDL …

In atherosclerosis; blood low-density lipoproteins (LDL) are subjected to multiple enzymatic
and non-enzymatic modifications that increase their atherogenicity and induce …

Advanced glycation end products (AGEs) are a diverse group of compounds produced when
reducing sugars react with proteins or other compounds to form glycosylated molecules …

Diabetic retinopathy (DR), a leading cause of acquired vision loss, is a microvascular
complication of diabetes. While traditional risk factors for diabetic retinopathy including …

We aimed to explore the association of advanced oxidation and advanced glycation of
proteins, and their interrelations with endothelial nitric oxide synthesis, oxidative stress …

We evaluated the effects of curcumin treatment on protein oxidation (PO), lipid peroxidation
(LP) and brain-derived neurotrophic factor (BDNF) levels in the hippocampus and frontal …